Učitavanje...
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees
BACKGROUND: Germline mutations in the BRCA2 gene have been suggested to account for about 5% of familial prostate cancer; mutations have been reported in 2% of early onset (i.e., ≤ 55 years) prostate cancer cases and a segregating founder mutation has been identified in Iceland (999del5). However, t...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2694822/ https://ncbi.nlm.nih.gov/pubmed/19476645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-2-94 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|